These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Comparison of candoxatril and atrial natriuretic factor in healthy men. Effects on hemodynamics, sympathetic activity, heart rate variability, and endothelin. Ando S; Rahman MA; Butler GC; Senn BL; Floras JS Hypertension; 1995 Dec; 26(6 Pt 2):1160-6. PubMed ID: 7498988 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of kidney neutral endopeptidase after administration of the neutral endopeptidase inhibitor candoxatril: quantitation by autoradiography. Yoshida K; Kanazawa M; Casley DJ; Katopothis A; Johnston CI J Cardiovasc Pharmacol; 1998 Nov; 32(5):702-8. PubMed ID: 9821842 [TBL] [Abstract][Full Text] [Related]
8. Effects of SA7060, a novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, on deoxycorticosterone acetate-salt-induced hypertension in rats. Kuro T; Okahara A; Nose M; Ikuse T; Matsumura Y Biol Pharm Bull; 2000 Jul; 23(7):820-5. PubMed ID: 10919359 [TBL] [Abstract][Full Text] [Related]
9. Dual inhibition of angiotensin converting enzyme and neutral endopeptidase produces effective blood pressure control in spontaneously hypertensive rats. Kostova E; Jovanoska E; Zafirov D; Jakovski K; Maleska V; Slaninka-Miceska M Bratisl Lek Listy; 2005; 106(12):407-11. PubMed ID: 16642666 [TBL] [Abstract][Full Text] [Related]
10. Hemodynamic and neuroendocrine effects for candoxatril and frusemide in mild stable chronic heart failure. Westheim AS; Bostrøm P; Christensen CC; Parikka H; Rykke EO; Toivonen L J Am Coll Cardiol; 1999 Nov; 34(6):1794-801. PubMed ID: 10577572 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of endopeptidase inhibition (candoxatril) in congestive heart failure. Elsner D; Müntze A; Kromer EP; Riegger GA Am J Cardiol; 1992 Aug; 70(4):494-8. PubMed ID: 1386491 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the short-term effects of candoxatril, an orally active neutral endopeptidase inhibitor, and frusemide in the treatment of patients with chronic heart failure. Northridge DB; Newby DE; Rooney E; Norrie J; Dargie HJ Am Heart J; 1999 Dec; 138(6 Pt 1):1149-57. PubMed ID: 10577447 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of endopeptidase EC 3.4.24.11 by candoxatril lowered blood pressure and increased urinary but not plasma atrial natriuretic peptide in essential hypertension. Tunny TJ; Ziesak MD; Armstrong R; Klemm SA; Stowasser M; Finn WL; Gordon RD J Hypertens Suppl; 1993 Dec; 11(5):S222-3. PubMed ID: 8158355 [No Abstract] [Full Text] [Related]
14. Omapatrilat, a dual angiotensin-converting enzyme and neutral endopeptidase inhibitor, prevents fatty streak deposit in apolipoprotein E-deficient mice. Arnal JF; Castano C; Maupas E; Mugniot A; Darblade B; Gourdy P; Michel JB; Bayard F Atherosclerosis; 2001 Apr; 155(2):291-5. PubMed ID: 11254898 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms underlying the augmented responses of deoxycorticosterone acetate-salt hypertensive rats to neutral endopeptidase inhibitors. Hirata Y; Suzuki Y; Suzuki E; Hayakawa H; Kimura K; Goto A; Omata M; Minamino N; Kangawa K; Matsuo H J Hypertens; 1994 Apr; 12(4):367-74. PubMed ID: 8064160 [TBL] [Abstract][Full Text] [Related]
16. Neutral endopeptidase inhibitor versus angiotensin converting enzyme inhibitor in a rat model of the metabolic syndrome. Eizenberg Y; Grossman E; Peleg E; Shabtai Z; Sharabi Y J Am Soc Hypertens; 2014 Apr; 8(4):227-31. PubMed ID: 24560177 [TBL] [Abstract][Full Text] [Related]
17. Characterization of atrial natriuretic peptide in urine from rats treated with a neutral endopeptidase inhibitor. Suzuki E; Hirata Y; Matsuoka H; Sugimoto T; Hayakawa H; Sugimoto T; Kangawa K; Minamino N; Matsuo H Biochem Biophys Res Commun; 1992 Feb; 182(3):1270-6. PubMed ID: 1531753 [TBL] [Abstract][Full Text] [Related]
18. Dietary sodium and inhibition of neutral endopeptidase 24.11 in essential hypertension. Singer DR; Markandu ND; Buckley MG; Miller MA; Sagnella GA; MacGregor GA Hypertension; 1991 Dec; 18(6):798-804. PubMed ID: 1835959 [TBL] [Abstract][Full Text] [Related]
19. Lack of correlation of hypotensive effects with prevention of cardiac hypertrophy by perindopril after ligation of rat coronary artery. Chiba K; Moriyama S; Ishigai Y; Fukuzawa A; Irie K; Shibano T Br J Pharmacol; 1994 Jul; 112(3):837-42. PubMed ID: 7921610 [TBL] [Abstract][Full Text] [Related]